DLH HOLDINGS CORP (DLHC) Stock Fundamental Analysis
USA - NASDAQ:DLHC - US23335Q1004 - Common Stock
5.5 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to DLHC. DLHC was compared to 83 industry peers in the Professional Services industry. DLHC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DLHC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DLHC was profitable.
In the past year DLHC had a positive cash flow from operations.
In the past 5 years DLHC has always been profitable.
Each year in the past 5 years DLHC had a positive operating cash flow.
1.2 Ratios
The Return On Assets of DLHC (1.53%) is comparable to the rest of the industry.
DLHC's Return On Equity of 4.03% is in line compared to the rest of the industry. DLHC outperforms 46.34% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.51%, DLHC is in line with its industry, outperforming 50.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DLHC is in line with the industry average of 12.76%.
The last Return On Invested Capital (6.51%) for DLHC is well below the 3 year average (11.89%), which needs to be investigated, but indicates that DLHC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.53% | ||
| ROE | 4.03% | ||
| ROIC | 6.51% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
1.3 Margins
DLHC's Profit Margin of 1.27% is in line compared to the rest of the industry. DLHC outperforms 45.12% of its industry peers.
In the last couple of years the Profit Margin of DLHC has declined.
DLHC's Operating Margin of 5.81% is in line compared to the rest of the industry. DLHC outperforms 53.66% of its industry peers.
DLHC's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 19.88%, DLHC is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
DLHC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.81% | ||
| PM (TTM) | 1.27% | ||
| GM | 19.88% |
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DLHC is creating some value.
Compared to 1 year ago, DLHC has more shares outstanding
DLHC has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DLHC has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.76, we must say that DLHC is in the distress zone and has some risk of bankruptcy.
DLHC has a Altman-Z score of 1.76. This is in the lower half of the industry: DLHC underperforms 68.29% of its industry peers.
The Debt to FCF ratio of DLHC is 5.74, which is a neutral value as it means it would take DLHC, 5.74 years of fcf income to pay off all of its debts.
DLHC has a Debt to FCF ratio (5.74) which is in line with its industry peers.
DLHC has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of DLHC (1.09) is worse than 71.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.09 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.65
WACC9.98%
2.3 Liquidity
DLHC has a Current Ratio of 1.08. This is a normal value and indicates that DLHC is financially healthy and should not expect problems in meeting its short term obligations.
DLHC has a worse Current ratio (1.08) than 70.73% of its industry peers.
DLHC has a Quick Ratio of 1.08. This is a normal value and indicates that DLHC is financially healthy and should not expect problems in meeting its short term obligations.
DLHC's Quick ratio of 1.08 is on the low side compared to the rest of the industry. DLHC is outperformed by 70.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
DLHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.25%.
Measured over the past 5 years, DLHC shows a small growth in Earnings Per Share. The EPS has been growing by 1.22% on average per year.
The Revenue for DLHC has decreased by -10.30% in the past year. This is quite bad
Measured over the past years, DLHC shows a quite strong growth in Revenue. The Revenue has been growing by 19.81% on average per year.
EPS 1Y (TTM)-37.25%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-75%
Revenue 1Y (TTM)-10.3%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-17.23%
3.2 Future
The Earnings Per Share is expected to decrease by -59.37% on average over the next years. This is quite bad
DLHC is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -21.79% yearly.
EPS Next Y-66%
EPS Next 2Y-59.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.41%
Revenue Next 2Y-21.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.19 indicates a rather expensive valuation of DLHC.
65.85% of the companies in the same industry are more expensive than DLHC, based on the Price/Earnings ratio.
DLHC is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for DLHC. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.19 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DLHC is valued cheaply inside the industry as 91.46% of the companies are valued more expensively.
DLHC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DLHC is cheaper than 98.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.28 | ||
| EV/EBITDA | 5.75 |
4.3 Compensation for Growth
DLHC's earnings are expected to decrease with -59.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)14.09
EPS Next 2Y-59.37%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for DLHC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DLHC (9/12/2025, 8:00:01 PM)
5.5
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners72.98%
Inst Owner Change9.71%
Ins Owners13.55%
Ins Owner Change0%
Market Cap79.14M
Analysts82.86
Price Target10.2 (85.45%)
Short Float %0.84%
Short Ratio1.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.96%
Min EPS beat(2)-15.97%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)9.18%
Min EPS beat(4)-15.97%
Max EPS beat(4)42.6%
EPS beat(8)4
Avg EPS beat(8)3.31%
EPS beat(12)6
Avg EPS beat(12)0.33%
EPS beat(16)8
Avg EPS beat(16)2.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.82%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-4.76%
Min Revenue beat(4)-8.25%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-3.95%
Revenue beat(12)1
Avg Revenue beat(12)-4.15%
Revenue beat(16)3
Avg Revenue beat(16)-2.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)50%
EPS NQ rev (3m)117.65%
EPS NY rev (1m)-10.53%
EPS NY rev (3m)230.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)27.27%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)8.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.19 | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | 3.28 | ||
| P/OCF | 3.23 | ||
| P/B | 0.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.75 |
EPS(TTM)0.32
EY5.82%
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)1.68
FCFY30.47%
OCF(TTM)1.71
OCFY31%
SpS25
BVpS7.9
TBVpS-8.37
PEG (NY)N/A
PEG (5Y)14.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.53% | ||
| ROE | 4.03% | ||
| ROCE | 8.24% | ||
| ROIC | 6.51% | ||
| ROICexc | 6.51% | ||
| ROICexgc | 86.01% | ||
| OM | 5.81% | ||
| PM (TTM) | 1.27% | ||
| GM | 19.88% | ||
| FCFM | 6.7% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
ROICexc(3y)11.91%
ROICexc(5y)11.55%
ROICexgc(3y)142.07%
ROICexgc(5y)N/A
ROCE(3y)15.05%
ROCE(5y)13.95%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-9.4%
ROICexc growth 3Y-17.74%
ROICexc growth 5Y-3.87%
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.09 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 3.29 | ||
| Cap/Depr | 2.51% | ||
| Cap/Sales | 0.12% | ||
| Interest Coverage | 1.45 | ||
| Cash Conversion | 64.97% | ||
| Profit Quality | 526.26% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 1.76 |
F-Score7
WACC9.98%
ROIC/WACC0.65
Cap/Depr(3y)6.77%
Cap/Depr(5y)4.74%
Cap/Sales(3y)0.2%
Cap/Sales(5y)0.14%
Profit Quality(3y)813.86%
Profit Quality(5y)632.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-37.25%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-75%
EPS Next Y-66%
EPS Next 2Y-59.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.3%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-17.23%
Revenue Next Year-13.41%
Revenue Next 2Y-21.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.78%
EBIT growth 3Y10.79%
EBIT growth 5Y16.91%
EBIT Next Year46.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.84%
FCF growth 3Y-16.5%
FCF growth 5Y8.52%
OCF growth 1Y16.84%
OCF growth 3Y-15.69%
OCF growth 5Y8.69%